Early Stage Presenting Companies
Main Stage Presenting Companies
Click here to listen to audio interviews with several Venture '05 presenting companies.
Asklepios BioPharmaceutical, Inc. (Chapel Hill, NC - www.askbio.com) is developing cellular-based, protein therapies using its proprietary biological nanoparticle (“BNP”) delivery technology to deliver a broad variety of biological material to a cell, including therapeutic genes, monoclonal antibodies, growth factors, vaccines and potential RNAi applications. The company is currently developing gene therapy treatments for Duchene's Muscular Dystrophy and Congestive Heart Failure. [Listen to this company's audio interview.]
CivaTech Corporation (Raleigh, NC) is a biomedical and radiation technology company focused on intravascular cardiology and cancer treatment. The company has developed a unique method for producing radioactive source materials for medical devices that could reduce the cost compared to competitive treatments. [Listen to this company's audio interview.]
Endacea, Inc. (RTP, NC - www.endacea.com), a development stage biopharmaceutical company, is developing a proprietary series of highly potent and highly selective A1 adenosine receptor antagonists. The lead compound, L-97-1, is being developed for the prevention and early treatment of asthma with a dual mechanism of action: prevention of both bronchoconstriction and inflammation. Endacea believes that this oral monotherapy will compete favorably with current market leaders, reducing or eliminating the need for inhaled steroids. Other indications for L-97-1 or one of its analogs include allergic rhinitis, chronic obstructive pulmonary disease, reperfusion injury of the heart and Gram-negative septicemia.
HexaTech, Inc. (Raleigh, NC – www.hexatechinc.com) is developing and producing single crystalline aluminum nitride (AlN) substrates for high performance electronic and optoelectronic devices. The company’s technology is based on extensive research conducted at North Carolina State University.
Instancy, Inc. (Cary, NC – www.instancy.com) offers a software-as-a-service solution that automates, manages and monitors knowledge-workflows between customer-facing teams (internal teams and external vendors) and customers. Instancy’s technology platform ensures that the right business intelligence and knowledge can be delivered to any device in real-time.
Liquidia Technologies (Chapel Hill, NC - www.liquidia.com) develops and markets innovative fluoropolymer materials for high-value industrial applications in a broad range of industries including chemical, life science, electronic, and consumer goods companies. The company's technology platform was developed in labs of Professors Joseph DeSimone and Edward Samulski at UNC-Chapel Hill.
Mardil, Inc. (Morrisville, NC - www.mardil.com) is focused on developing minimally invasive procedures and devices for the cardiovascular disease market. The company plans to design, develop and market new devices related to the treatment of Congestive Heart Failure, including mitral regurgitation, by improving upon the existing technology to meet a current unmet need. [Listen to this company's audio interview.]
Navigational Sciences, Inc. (Asheville, NC – www.navsci.com) is creating an intermodal (cargo, container, ship, road, and rail) global security monitoring and asset tracking system called the Marine Transportation Control System (“MTCS”). The company’s system will be used to create a real-time asset tracking, tracing and sensing solution for shipping containers as they move globally.
Refense Technologies (Raleigh, NC - www.refense.com) is a security software company providing solutions to secure sensitive data and network devices from attacks. The company's flagship product, Network Device Scanner, provides a solution to proactively identify vulnerabilities within wireless and wired network devices.
Salzburg Therapeutics (Yadkinville, NC) is developing “Cytotoxamers” for treatment of cancer and infectious disease. Cytotoxamers have the power of cytotoxic drugs to kill cancer cells, but they are highly selective and do not harm non-malignant cells. The company’s initial product development is a Cytotoxamer for treatment of late-stage prostate cancer.
Triad Semiconductor, Inc. (Winston-Salem, NC - www.triadsemi.com) uses patent pending integrated circuit (IC) design architectures and its proprietary electronic design tools to configure an array fundamental analog and digital circuit elements into custom chips. The company's mixed-signal structured array technology reduces time to market and development cost for application specific integrated circuits (ASICs).
TxFS (Raleigh, NC www.txfs.com) offers a direct-to-bill payment network that lets consumers charge purchases of digital content -- music, movies, games, etc. -- to their Internet service provider bill. This provides consumers with a secure, one-click purchase option, drives more sales for merchants, and offers ISPs a new value-added service and revenue stream. [Listen to this company's audio interview.]
WiMAX Systems (RTP, NC – www.wimaxsystems.net) is responding to the growing demand for wireless Internet access by developing products that enable individuals, businesses and governments to achieve wireless access with more simplicity. The company’s technology merges wide-area wireless, private networks and Internet services into one low-cost solution.
Zenph Studios (Raleigh, NC – www.zenph.com) is a software company focused on digital techniques that can improve music interpretation, performance and recording. Zenph’s services and software products are being developed to change how music is created, analyzed and preserved.
Affinergy (RTP, NC www.affinergy.com) develops “biological glues” for controlling biology at the convergence of therapeutics and medical devices. Their primary market is the $14 billion orthopedic market. By controlling delivery of various growth factors such as BMP and cell types (stem cells, osteoblasts), Affinergy improves integration of devices into the body, reduces healthcare costs and improves patient outcomes. [Listen to this company's audio interview.]
Amphora Discovery Corp. (RTP, NC www.amphoracorp.com) discovers and develops novel, pharmaceutical products both independently and with partners. Amphora's proprietary, predictable, microfluidics-based system accelerates the discovery of new drugs and expands intellectual property coverage of drug candidate compounds and classes of related compounds. [Listen to this company's audio interview.]
Arsenal Digital Solutions (Cary, NC www.arsenaldigital.com) provides data management services on a global basis that helps its customers with a wide range of solutions for data protection, business continuity and data recoverability.
Covelight Systems, Inc. (Cary, NC – www.covelight.com) has developed solutions that protect critical financial, trade secret and entrusted personal data from abuse, misuse and fraud by web-application users. Covelight’s patent-pending products deliver actionable intelligence in the form of real-time incident detection and notification, operational and security analytics and forensic audit trails to police an enterprise’s web community and ensure its users are held accountable. [Listen to this company's audio interview.]
Gentris Corporation (Morrisville, NC www.gentris.com) is a global provider of applied clinical pharmacogenomic services and diagnostic product solutions. Gentris helps pharmaceutical companies and clinical research organizations integrate pharmacogenomics into their drug development programs that will result in early elimination of poor drug candidates and delivery of safer, more effective compounds to the market sooner.
Inlet Technologies (Raleigh, NC – www.inlethd.com) provides professional encoding solutions for high-definition content creation and distribution. Inlet’s solutions combine the leading advanced compression encoding format with proprietary analysis tools to enable intelligent, real-time encoding of high-definition content for the post-production, broadcast and IPTV markets. [Listen to this company's audio interview.]
Integrian, Inc. (RTP, NC - www.integrian.com) is a mobile digital video company providing digital video solutions that allow customers to capture, tag, archive, view and search digital video for various security and informational purposes. Markets served by Integrian include the public safety and transit industries.
Merrion Pharmaceuticals, Inc. (Wilmington, NC www.merrionpharma.com) is an international specialty pharmaceutical company, focused on applying advanced drug delivery technologies for life cycle management of existing products, and enabling commercialization of biotechnology compounds. The company develops its own products, but it also makes its proprietary delivery technologies available to partners.
Mi-Co (RTP, NC – www.mi-corporation.com) provides digital writing software for capturing and communicating handwritten data. Mi-Co’s enterprise Mi-Forms Software System enables flexible e-forms design for data capture using digital ink. [Listen to this company's audio interview.]
Oriel Therapeutics Inc. (Durham, NC - www.orieltherapeutics.com) is a drug delivery company using powder inhalation technology developed at UNC-Chapel Hill and licensed on an exclusive basis to the company. Oriel is focused on the development of a novel active Dry Powder Inhaler for the delivery of drugs to the lungs for the treatment of asthma and chronic obstructive pulmonary disease. [Listen to this company's audio interview.]
Qualyst, Inc. (RTP, NC www.qualyst.com), a spinout from UNC-Chapel Hill, provides novel ADMET (absorption, distribution, metabolism, excretion, and toxicity) technologies and related products to the life science industry. The technologies developed by Qualyst show significant improvements over existing technology with respect to their speed of use and analysis, and the quality of information provided.
Respirics, Inc. (Raleigh, NC - www.respirics.com) is a respiratory drug delivery and development company serving the pharmaceutical, biotechnology and diagnostic industries. Respirics has developed a dry powder respiratory drug delivery system that can incorporate a range of drug products to treat respiratory diseases as well as other diseases where systemic drug targeting is required. [Listen to this company's audio interview.]
StemCo Biomedical Inc. (Durham, NC - www.stemcobiomedical.com) is developing and commercializing proprietary products that improve the identification and selection of more effective adult stem cell populations for use in the treatment of cancer and cardiovascular diseases and for other regenerative medicine applications. The expanded applications of StemCo's platform technology will include autoimmune diseases, anemias, tissue regeneration and cell plasticity.
Stonewall Networks, Inc. (Cary, NC) is focused on the security management market regarding security policy management. The company is leveraging a patented use of XML technology to deliver a security management product called Cornerstone that encompasses security policy management, threat detection, threat reporting and threat mitigation for a multi-vendor environment.
TapRoot Systems, Inc. (Morrisville, NC www.taprootsystems.com) provides embedded software components for smartphone manufacturers and wireless operators worldwide. The company offers off-the-shelf software products that support a suite of communications protocols for Symbian OS and other smartphone operating systems.
TelecommUSA (Charlotte, NC), is a consumer financial services company offering money transfer and related services including bill payment, phone card, cash card, direct marketing and technology licensing. The company’s patented technology enables easy fund transfer transactions from retail checkout counters and other locations. The Company is currently focusing its efforts on the booming Hispanic market.
Biolex, Inc. (Pittsboro, NC www.biolex.com) utilizes its transformational LEX System to develop recombinant human therapeutic proteins that, until now, have been impossible or very expensive to develop in existing protein expression systems. Biolex is developing its own pipeline of hard-to-make proteins and monoclonal antibodies, and, in parallel, is establishing partnerships with a number of top-tier pharmaceutical and biotechnology companies.
LVL7 Systems, Inc. (Morrisville, NC www.lvl7.com) offers a go-to-market model for providers of Ethernet and IP communication systems. The company creates production-ready networking software that enables networking original equipment manufacturers (OEMs) and original design manufacturers (ODMs) to reduce development expenses and compress development timelines.
Motricity (Durham, NC www.motricity.com) is a provider of mobile content infrastructure to the wireless industry. The company reaches mobile subscribers with its market-leading Fuel mobile content delivery platform through global partners such as Verizon Wireless, mmO2, Amazon.com, palmOne and many others. The company is also one of the largest providers of mobile content through its network of consumer websites and channel partnerships, reaching over 10 million consumers worldwide. [Listen to this company's audio interview.]
Click here to view the Venture Presenting Company Applicant Criteria.
Questions? Contact Liza Lamberto at llamberto@cednc.org or 919.549.7500 x116.
Click here to see who presented at Venture 2004.